Gemcitabine Hydrochloride for Injection trials for Breast cancer

All Gemcitabine Hydrochloride for Injection trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Gemcitabine Hydrochloride for Injection for Breast cancer

• A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
  NCT07544056 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
  NCT06202261 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 87 locations

Common questions

How many trials study Gemcitabine Hydrochloride for Injection for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.